I hope I find the right words for this post because words were what Randy Alexander was all about, along with a deep love for the New Jersey and Philadelphia entertainment scene and the people in it. Randy Alexander passed away Sunday, Dec. 27 after a four month battle with pancreatic cancer. He was 62.
I first met Randy back in the 80 s when he was a TV/Radio reporter for the Trenton Times. He was so good at his job that His coverage of Bruce Springsteen’s Born in the U.S.A. tour was included in the 1996 biography “Glory Days,” written by Dave Marsh, according to his bio.
Remembering those who succumbed to pancreatic cancer dnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dnews.com Daily Mail and Mail on Sunday newspapers.
Year in Review: PanCAN’s Community Gets Creative by
Share
Email
Nothing stops the Pancreatic Cancer Action Network (PanCAN) community from taking action against pancreatic cancer. And in 2020, we saw how powerful you are.
PurpleStride Maryland masked up and stayed safe while raising funds and awareness to fight pancreatic cancer.
From pivoting to virtual PurpleStride without missing a step to enthusiastic personal fundraising through Wage Hope My Way and Facebook, you masked up, socially distanced and put your purple passion on full display. Our committed volunteer leaders continued moving forward with important training and development via our virtual PanCAN Academy series and ongoing Zoom Affiliate meetings and strategizing.
Budget Passed By Congress Includes Increase In Federal Funding For Cancer Research
Advocates From Pancreatic Cancer Action Network Were Instrumental in Securing Bipartisan Support For Pancreatic Cancer Research at Department of Defense
News provided by
Share this article
Share this article
LOS ANGELES, Dec. 22, 2020 /PRNewswire/ Congress delivered a key victory for pancreatic cancer patients and researchers today by passing its Fiscal Year (FY) 2021 budget. In response to the advocacy efforts of the Pancreatic Cancer Action Network (PanCAN), the spending package includes $15 million for the Department of Defense s (DoD) dedicated Pancreatic Cancer Research Program, more than doubling last year s inaugural investment. In addition, the package includes an overall increase in the nation s investment in biomedical research funding of $42.9 billion to the National Institutes of Health (NIH) and $6.56 billion to the National Cancer Institute (NCI).
AIM ImmunoTech Inc.
AIM ImmunoTech Inc.’s Drug Ampligen Awarded FDA’s Orphan Drug Designation Status for the Treatment of Pancreatic Cancer
AIM ImmunoTech Inc.’s Drug Ampligen Awarded FDA’s Orphan Drug Designation Status for the Treatment of Pancreatic Cancer
OCALA, Fla., Dec. 21, 2020 (GLOBE NEWSWIRE) AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today announced that the U.S. Food and Drug Administration on December 17, 2020 granted Orphan Drug Designation status to AIM’s drug Ampligen (rintatolimod) for the treatment of pancreatic cancer.